Literature DB >> 35068214

In vitro contractile studies within isolated tissue baths: Translational research from Visible Heart® Laboratories.

Weston J Upchurch1,2, Paul A Iaizzo1,2,3.   

Abstract

The isolated tissue bath research methodology was first developed in 1904. Since then, it has been recognized as an important tool in pharmacology and physiology research, including investigations into neuromuscular disorders. The tissue bath is still used routinely as the instrument for performing the "gold standard" test for clinical diagnosis of malignant hyperthermia susceptibility - the caffeine-halothane contracture test. Our research group has utilized this tool for several decades for a range of research studies, and we are currently one of four North American diagnostic centers for determining susceptibility for malignant hyperthermia. This review provides a brief summary of some of the historical uses of the tissue bath. Important experimental considerations for the operation of the tissue bath are further described. Finally, we discuss the different studies our group has performed using isolated tissue baths to highlight the broad potential applications.

Entities:  

Keywords:  Organ bath; contracture testing; isolated tissue bath; malignant hyperthermia; muscle bath

Mesh:

Substances:

Year:  2022        PMID: 35068214      PMCID: PMC9014520          DOI: 10.1177/15353702211070535

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  68 in total

Review 1.  Length dependence of active force production in skeletal muscle.

Authors:  D E Rassier; B R MacIntosh; W Herzog
Journal:  J Appl Physiol (1985)       Date:  1999-05

2.  Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine.

Authors:  D C Sigg; P A Iaizzo
Journal:  Anesthesiology       Date:  2000-06       Impact factor: 7.892

3.  Receptor theory.

Authors:  Terry Kenakin
Journal:  Curr Protoc Pharmacol       Date:  2008-06

4.  Halothane-induced muscle contracture as a cause of hyperpyrexia.

Authors:  F R Ellis; D G Harriman; N P Keaney; K Kyei-Mensah; J H Tyrrell
Journal:  Br J Anaesth       Date:  1971-07       Impact factor: 9.166

Review 5.  Predictivity of in vitro non-clinical cardiac contractility assays for inotropic effects in humans--A literature search.

Authors:  Rob Wallis; Mayel Gharanei; Helen Maddock
Journal:  J Pharmacol Toxicol Methods       Date:  2015-05-27       Impact factor: 1.950

6.  The effects of temperature on cardiac pacing thresholds.

Authors:  Mark T Marshall; Kenneth K Liao; Michael K Loushin; Paul A Iaizzo
Journal:  Pacing Clin Electrophysiol       Date:  2010-01-26       Impact factor: 1.976

7.  The dose makes the poison.

Authors:  Liang Chen; John P Giesy; Ping Xie
Journal:  Sci Total Environ       Date:  2017-12-01       Impact factor: 7.963

Review 8.  Ionic mechanisms and Ca2+ handling in airway smooth muscle.

Authors:  S Hirota; P Helli; L J Janssen
Journal:  Eur Respir J       Date:  2007-07       Impact factor: 16.671

9.  Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice.

Authors:  Kristen A Baltgalvis; Michele A Jaeger; Daniel P Fitzsimons; Stanley A Thayer; Dawn A Lowe; James M Ervasti
Journal:  Skelet Muscle       Date:  2011-10-13       Impact factor: 4.912

10.  Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I.

Authors:  Karim Azzag; Carolina Ortiz-Cordero; Nelio A J Oliveira; Alessandro Magli; Sridhar Selvaraj; Sudheer Tungtur; Weston Upchurch; Paul A Iaizzo; Qi Long Lu; Rita C R Perlingeiro
Journal:  Skelet Muscle       Date:  2020-04-22       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.